Diabetes Research Paper

Abstract
With the advances in technology over the past 10 years, medical monitoring has advanced from wired monitors, such as with diabetes patients, who must manually input their glucose levels into an insulin pump attached to the belt to the wireless NUVANT Mobile Cardiac Telemetry System for patients with cardiac arrhythmia. This device allows the patient to record his heart rhythms and upload them to a wireless transmitter, which then send the data to the doctor. Other advances in medical monitoring involve the use of a patient’s smartphone to monitor the patient’s medical conditions and transmit directly to the cloud or email the results directly to the doctor for interpretation. This paper discusses the advances made in medical monitoring
This could be due to lack of the hormone insulin, or because the insulin that is available is not working effectively (Mandal). According to the 2011 Data National Fact Sheet 8.3% people in the United States have diabetes. Patients who suffer from IDDM (insulin dependent diabetes mellitus) suffer from their pancreas not creating enough insulin or their body ignoring the insulin altogether. Uncontrolled diabetes can result in amputation, blindness, heart disease and stroke, kidney failure and high blood pressure. More diabetics have found that using an insulin therapy pump is much easier than having to carry around insulin that has to be measured for the appropriate dosage amount and oftentimes kept refrigerated. People with diabetes must check their glucose levels up to 4 times a day or more often if they are experiencing high sugar levels by using a glucose monitor. Using the glucose monitor, patients will lance their fingers and take a small sample of their blood and place it onto a test strip that will be inserted into the monitor; within seconds patients will have their glucose levels reported back. Currently, patients must manually enter the glucose levels into an insulin pump where the appropriate amount of insulin will be dispensed into the body via a needle that is inserted into the body subcutaneously, and the insulin will travel through tubing connected from the insulin pump
Have we reached the limits of our ability to monitor these medical conditions, or is the sky really the limit? In truth, the answer to that question is mixed. Speaking strictly regarding whether the technology will exist to accommodate the need for more advanced and less restrictive monitoring methods, there is no reason to assume that such advancements could not be achieved. However, in light of laws and regulations such as HIPAA, the ongoing issues of tort and the potential for lawsuits that these technological advancements could pave the way toward, it is impossible to determine whether or not our legal reach will exceed our technological